LORTUSS DM is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Sallus Laboratories, Llc. The primary component is Dextromethorphan Hydrobromide; Doxylamine Succinate; Pseudoephedrine Hydrochloride.
| Product ID | 69036-120_41999ae8-18fc-49a0-a55c-ffa00f353ddd |
| NDC | 69036-120 |
| Product Type | Human Otc Drug |
| Proprietary Name | LORTUSS DM |
| Generic Name | Dextromethorphan Hydrobromide, Doxylamine Succinate, Pseudoephedrine Hydrochloride |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-06-14 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Sallus Laboratories, LLC |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Active Ingredient Strength | 15 mg/5mL; mg/5mL; mg/5mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2014-06-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2014-06-14 |
| Marketing End Date | 2019-12-31 |
| Inactivation Date | 2019-11-27 |
| Reactivation Date | 2020-05-13 |
| Ingredient | Strength |
|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 15 mg/5mL |
| SPL SET ID: | 8afe55f6-7cb4-47c3-946d-6fa0126c23da |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LORTUSS 88817798 not registered Live/Pending |
Key Therapeutics, llc 2020-03-02 |
![]() LORTUSS 78149278 2818425 Dead/Cancelled |
KOWA PHARMACEUTICALS AMERICA, INC. 2002-07-31 |
![]() LORTUSS 74276053 not registered Dead/Abandoned |
WHITBY PHARMACEUTICALS, INC. 1992-05-18 |